September 22, 2026, 12pm-1pm ET
Culturally grounded, community-based, and self-determined dementia risk reduction research in Northwestern Ontario with Brittany Skov
Many First Nations, Métis, and Inuit peoples experience a greater risk of dementia, influenced by social determinants of health shaped by the ongoing legacy of colonization. Despite this, substantial gaps exist in dementia risk reduction research with First Nations, Métis, and Inuit communities. It is now crucial to enhance engagement and collaboration with these communities to promote meaningful partnerships and outcomes in dementia research.
As a First Nations-led research team working on self-determined dementia research in Northwestern Ontario, we have incorporated our cultural knowledge, values, practices, and worldviews into our research to ensure that it not only increases knowledge about how to better reduce risk for community members living at risk for dementia, but also respects, honours, and revitalizes these values while promoting brain health.
In this way, our approach fosters brain health both in the process and in the outcome. We hope that sharing our approach contributes to continued efforts towards respectful collaborations between dementia risk reduction researchers and Indigenous communities. Our research team comprises First Nations and non-Indigenous university-based researchers, health professionals, and leaders from a First Nations-led and governed regional health organization in Northwestern Ontario, Canada.
We will share our approach through two research projects: the Wholistic Brain Health Assessment Bundle Project, a national, multi-community site project with multiple project outcomes, and the Anishinabek Brain Aging in Older Adults Study, a regional project aimed at learning about cultural perspectives on risk reduction for First Nations people in Northwestern Ontario. These projects have fostered self-determined dementia research through engaging in multi-pronged regional engagement pathways with multiple Indigenous communities, land-based research methodologies and activities, cultural protocols and values, reciprocity, non-hierarchical and intergenerational relationships, and creative data collection activities that promote brain health through social engagement, social connection, activities, traditional medicine, and land-based diets.
This methodological approach to health services research has ensured that our research fosters brain health in both process and outcome, maintains alignment with community needs, and provides the necessary research evidence to support continued self-determined approaches to addressing dementia risk reduction in Canada. Many First Nations, Métis, and Inuit are at a higher risk for developing dementia, requiring self-determined, collaborative, and culturally safe community-based and led research. Such approaches may provide a pathway to address this growing national public health concern.
Please note that registration is required to attend. Click here to register.
Past webinars
What are you looking for?
The role of psychosocial, lifestyle, and health factors in cognitive and brain aging
May 19, 2026
“You have to be there”: Emotional labor, cultural ethics, and the realities of Black families of people with dementia in Canada during COVID-19
February 17, 2026
Caring for the family caregiver: Lived experiences of family caregivers and mindfulness-based interventions for older adult caregivers of persons with dementia
January 20, 2026
Developing Dementia Decoded: Acute Care Dementia Strategy at The Ottawa Hospital
December 16, 2025
Using plasma biomarkers to estimate the prevalence of Alzheimer’s Disease pathology in COMPASS-ND
November 17, 2025
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research
May 20, 2025
The content of this webinar is based on this scientific review paper: Smith E. et al. (2025), Use of Lecanemab and Donanemab in the Canadian Healthcare System: Evidence, Challenges, and Areas for Future Research. Journal of Prevention of Alzheimer’s Disease.
Visit this page for frequently asked questions about the use of new medications for Alzheimer’s disease in the Canadian healthcare system
Dementia-related apathy: Recent advances in diagnosis and treatment
April 29, 2025
This presentation is based on this scientific review paper: Lanctôt K.L. et al. (2023) Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders. International Journal of Geriatric Psychiatry. Feb., 38(2):e5882.
Consult this page for an infographic tool for clinicians on distinguishing apathy from depression in neurocognitive disorders
Brain rhythms, proteinopathy, and neurochemistry along the Alzheimer’s disease continuum
February 5, 2025
Food on the brain: Nutrition in Indigenous communities
December 10, 2024
Navigating risk-taking in the presence of anosognosia: Decision-making capacity challenges in Alzheimer’s disease
December 3, 2024
Modest dietary carbohydrate restriction to sustain healthy cognitive aging
October 8, 2024
Sex and Gender research in CCNA: A sampling of current projects and future directions
April 23, 2024





